Recruiting soon

Composite WM Formula for Body Weight Change Prevention

Study Aim

This study, with a Composite WM Formula, aims to prevent body weight change in individuals. It will assess changes in weight, GLP-1 concentration, and blood glucose at various time points.

What is being tested

WM formula liquid drink

+ Placebo

Dietary Supplement

Who is being recruted

Body Weight+9

+ Hyperinsulinism

+ Insulin Resistance

Over 18 Years

+12 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Prevention Study

Placebo-Controlled

Interventional

Study Start: August 2025

See protocol details

Summary

Principal SponsorTCI Co., Ltd.

Study ContactTong-Lin Wu

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: August 31, 2025

Actual date on which the first participant was enrolled.

This clinical trial aims to investigate whether the WM Formula supplement can help change body weight. It focuses on adults aged 18 and older, selected based on their waist size or body fat percentage. The study is important as it seeks to offer a new way to manage body weight, potentially providing an effective solution for those struggling with weight-related health issues. Participants are divided into two groups, with one group taking the WM Formula supplement and the other taking a placebo, a substance with no active ingredients. Over four weeks, participants will have their height, weight, blood pressure, and other health markers checked at the start, middle, and end of the study. They will also fill out questionnaires about their appetite and any digestive changes they experience. This helps researchers understand if the supplement affects weight and appetite without causing unwanted side effects.

Official TitleEvaluation of the Efficacy of the Composite WM Formula in Body Weight Change

NCT07097974

Principal SponsorTCI Co., Ltd.

Study ContactTong-Lin Wu

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

40 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Body WeightHyperinsulinismInsulin ResistanceMetabolic DiseasesNutrition DisordersNutritional and Metabolic DiseasesObesitySigns and SymptomsPathological Conditions, Signs and SymptomsOvernutritionGlucose Metabolism DisordersOverweight

Criteria

3 inclusion criteria required to participate

Adults aged 18 years or older who are willing to sign the informed consent form.

Body fat percentage: ≥30% for females and ≥25% for males.

Non-pregnant and non-lactating women who agree to use physical contraceptive methods (e.g., condoms, intrauterine devices) throughout the study period.

9 exclusion criteria prevent from participating

Use of GLP-1 receptor agonists approved in Taiwan (e.g., liraglutide, semaglutide, dulaglutide), blood glucose-regulating medications, weight loss-related drugs or functional foods, probiotics, or gastrointestinal health-related supplements or medications within 30 days prior to the start of the study.

History of chronic gastrointestinal disorders, seizure disorders or epilepsy, hepatic or renal diseases, malignancies, endocrine disorders, psychiatric illnesses, alcohol or drug abuse, or other major organic diseases based on medical history.

History of gastrointestinal surgery, organ transplantation, or other major surgeries.

History of hypoglycemia.

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

2 intervention groups are designated in this study

50% chance of being blinded to the placebo group

Treatment Groups

Group I

Experimental

WM formula liquid drink, 50 g/glass jar

Group II

Placebo

The placebo contained the same base ingredients as the WM formula but without the active WM formula component.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

TCI Co., Ltd.

Taipei, TaiwanOpen TCI Co., Ltd. in Google Maps

Recruiting soonOne Study Center